TCL Archive House-Senate Conferees agree On NCI Total for FY’89, Then Cut It $19 Million August 26, 1988
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session November 16, 2012